Is Racial and Ethnic Representation in Oncology Clinical Trials Improving?

Health equity remains a critical priority in oncology, particularly ensuring that clinical trial enrollment accurately reflects the diverse populations impacted by cancer.

Read the full accompanying article on Oncology Data Advisor: https://oncdata.com/racial-ethnic-representation-oncology-clinical-trials

What You’ll Learn in This Episode:
🔹 AI Meets Trial Data: Understanding how multimodal large language models (LLMs) were utilized to automatically extract and evaluate three decades of demographic metrics from thousands of publication PDFs.
🔹 Exposing Enrollment Disparities: Analyzing why a dramatic tripling of trial demographic reporting has failed to translate into actual increased representation for Black and Hispanic communities in the US.
🔹 The Illusion of Global Progress: Exploring how international trial expansion, particularly in Asia, drives overall non-White participation data while domestic minority enrollment remains low or declines.
🔹 Structural Barriers to Participation: Evaluating the real-world operational and economic constraints—such as rigid follow-up schedules, travel distances, and dense language barriers—that hinder diverse patient accrual.
🔹 Fostering Equitable Research Environments: Actionable advice for investigators on leveraging pragmatic AI tools, like simplified consent language and patient-facing Q&A systems, to improve trial accessibility and trust.

Chapter Timestamps:
00:00 – Introduction: Diversity and Representation in Oncology Trials
01:15 – AI Meets Trial Data: Processing 30 Years of Research
02:50 – Key Findings: The Rise in Reporting vs. Actual Inclusion
04:30 – Global Trends vs. US Minority Underrepresentation
06:10 – Operational Obstacles and Structural Barriers to Enrollment
07:50 – Pragmatic AI Applications: Simplifying the Patient Consent Process
09:25 – Key Takeaways: Building an Equitable Oncology Research Landscape

About the Speakers:
Jiasheng Wang, MD, is an Assistant Professor of Hematology at The @OSUCCC_James – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. He specializes in the treatment of blood cancers with a holistic approach that considers each patient’s physical, mental, and social well-being.

Waqas Haque, MD, MPH, is a second-year Hematology/Oncology Fellow at the@UChicago. His research focuses on innovative clinical trial design, value-based care delivery to cancer patients, and clinical investigation.

Stay Connected:
Subscribe for more deep dives into oncology research and practice.
Website: https://oncdata.com/
Follow us on X/Twitter: @OncData

#Oncology #ClinicalTrials #HealthEquity #CancerResearch #AIinMedicine #ASCO #Hematology #DiversityInMedicine #OncologyDataAdvisor #MedEd

Видео Is Racial and Ethnic Representation in Oncology Clinical Trials Improving? канала Oncology Data Advisor